AbbVie's CEO succession is seen as a thoughtful, deliberate ...
AbbVie's CEO succession is seen as a thoughtful, deliberate move, planned for when the company has navigated the Humira exclusivity loss and the business is performing highly.
AbbVie Taps New CEO as It Faces Fresh Competition for Blockbuster Drug Humira
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment